HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.

Abstract
D-Glucose-6-phosphatase is a key regulator of endogenous glucose production, and its inhibition may improve glucose control in type 2 diabetes. Herein, 2'-O-(2-methoxy)ethyl-modified phosphorothioate antisense oligonucleotides (ASOs) specific to the glucose 6-phosphate transporter-1 (G6PT1) enabled reduction of hepatic D-Glu-6-phosphatase activity in diabetic ob/ob mice. Treatment with G6PT1 ASOs decreased G6PT1 expression, reduced G6PT1 activity, blunted glucagon-stimulated glucose production, and lowered plasma glucose concentration in a dose-dependent manner. In contrast to G6PT1 knock-out mice and patients with glycogen storage disease, excess hepatic and renal glycogen accumulation, hyperlipidemia, neutropenia, and elevations in plasma lactate and uric acid did not occur. In addition, hypoglycemia was not observed in animals during extended periods of fasting, and the ability of G6PT1 ASO-treated mice to recover from an exogenous insulin challenge was not impaired. Together, these results demonstrate that effective glucose lowering by G6PT1 inhibitors can be achieved without adversely affecting carbohydrate and lipid metabolism.
AuthorsKyle W Sloop, Aaron D Showalter, Amy L Cox, Julia X C Cao, Angela M Siesky, Hong Yan Zhang, Armando R Irizarry, Susan F Murray, Sheri L Booten, Eleftheria A Finger, Robert A McKay, Brett P Monia, Sanjay Bhanot, M Dodson Michael
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 282 Issue 26 Pg. 19113-21 (Jun 29 2007) ISSN: 0021-9258 [Print] United States
PMID17478431 (Publication Type: Journal Article)
Chemical References
  • Antiporters
  • Blood Glucose
  • Monosaccharide Transport Proteins
  • Oligoribonucleotides, Antisense
  • RNA, Messenger
  • glucose 6-phosphate(transporter)
  • Glycogen
  • Glucagon
  • Glucose-6-Phosphatase
Topics
  • Acidosis, Lactic (metabolism, prevention & control)
  • Animals
  • Antiporters (genetics, metabolism)
  • Blood Glucose (biosynthesis, metabolism)
  • Diabetes Complications (metabolism, prevention & control)
  • Diabetes Mellitus, Type 2 (metabolism, therapy)
  • Glucagon (metabolism)
  • Glucose-6-Phosphatase (metabolism)
  • Glycogen (metabolism)
  • Glycogen Storage Disease (metabolism, prevention & control)
  • Hyperlipidemias (metabolism, prevention & control)
  • Hyperuricemia (metabolism, prevention & control)
  • Hypoglycemia (metabolism, prevention & control)
  • Kidney (metabolism)
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Obese
  • Monosaccharide Transport Proteins (genetics, metabolism)
  • Oligoribonucleotides, Antisense (pharmacology)
  • RNA, Messenger (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: